Walgreens (NYSE: WAG) had its price target increased by Scotiabank from $47.00 to $50.00 in a research report released on Wednesday morning.

Other equities research analysts have also recently issued reports about the stock. Analysts at Guggenheim raised their price target on shares of Walgreens to $50.00 in a research note to investors on Wednesday. They now have a buy rating on the stock. Separately, analysts at Zacks reiterated a neutral rating on shares of Walgreens in a research note to investors on Wednesday. They now have a $47.00 price target on the stock. Finally, analysts at Morgan Stanley reiterated an equal weight rating on shares of Walgreens in a research note to investors on Wednesday.

One investment analyst has rated the stock with a sell rating, seven have given a hold rating and sixteen have issued a buy rating to the stock. Walgreens currently has a consensus rating of Buy and a consensus target price of $49.76.

Shares of Walgreens (NYSE: WAG) traded up 0.76% during mid-day trading on Wednesday, hitting $46.157. Walgreens has a one year low of $42.13 and a one year high of $46.33. The stock’s 50-day moving average is currently $44.3. The company has a market cap of $43.637 billion and a P/E ratio of 20.37.

Walgreen Co (NYSE: WAG), together with its subsidiaries, operates the drugstore chain in the United States.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.